Expanding access to new agents for children with refractory cancers: the experimental therapeutics program at Children's Hospital of Colorado.
|
Children’s Hospital Colorado / Lia Gore, MD |
Phase I/II Infrastructure Grants |
2009 |
Colorado |
BH3 profiling to define therapy resistance classes in neuroblastoma.
|
Children’s Hospital of Philadelphia / Michael Hogarty |
Innovation Grants |
2009 |
Pennsylvania |
Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma.
|
Huntsman Cancer Institute / Stephen Lessnick |
Innovation Grants |
2009 |
Utah |
Pediatric Oncology Translational Research Program |
Vanderbilt University Medical Center / James Whitlock, M.D. |
Phase I/II Infrastructure Grants |
2009 |
Tennessee |
Identifying Rare Genetic Variants Involved in High Risk Pediatric Leukemia Via Pooled Sequencing |
Washington University / Todd Druley, MD, PhD |
'A' Award Grants |
2009 |
Missouri |
Neuronal Damage, Neurocognitive Losses and Quality of Life Following High-Dose Chemotherapy in Children with Brain Tumors |
Children’s Hospital Los Angeles / Mary Nelson |
Nurse Researcher Grants |
2009 |
California |
A Pilot Study of the Feasibility and Acceptability of an Interactive Computerized Symptom Assessment Tool to Assess Disease and Treatment-Related Symptoms Experienced by Children with Cancer |
University of California San Francisco / Tina Baggott, RN, PhD, PNP |
Nurse Researcher Grants |
2009 |
California |
Exploring a novel immunotherapy: cooperation of endogenous CD8+ t-cells and exogenous, allogeneic CD4+ t-cells.
|
The Johns Hopkins University School of Medicine / Heather Symons |
Young Investigator Grants |
2009 |
Maryland |
Epigenetic manipulation of leukemia.
|
Cincinnati Children's Hospital Medical Center / H. Leighton Grimes |
Innovation Grants |
2009 |
Ohio |
Aberrant DNA methylation in Ewing sarcoma.
|
Fred Hutchinson Cancer Research Center / Scott Borinstein |
Young Investigator Grants |
2009 |
Washington |